On Friday, Sarepta Therapeutics Inc (NASDAQ:SRPT)’s shares declined -2.19% to $14.71.
Sarepta Therapeutics Inc (SRPT) stated financial results for the three months ended March 31, 2015, and offered an update of recent corporate developments.
Financial Results
For the first quarter of 2015, Sarepta stated a non-GAAP net loss of $47.4 million, or $1.15 per share, contrast to a non-GAAP net loss of $20.7 million for the first quarter of 2014, or $0.55 per share. The incremental loss of $26.7 million was primarily the result of raised operating expenses in addition to a decrease in revenue from the Company’s government contracts.
Revenue for the first quarter of 2015 reduced by $6.1 million primarily due to the July 2014 expiration of the Marburg portion of the Company’s Ebola-Marburg U.S. government contract.
Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases.
Synergy Pharmaceuticals Inc (NASDAQ:SGYP)’s shares dropped -2.17% to $3.60.
Synergy Pharmaceuticals Inc (SGYP) declared that its Chairman and Chief Executive Officer, Gary S. Jacob, Ph.D., will present a corporate update at the UBS Global Healthcare Conference on Wednesday May 20th at 12:00pm (EDT) at the Sheraton New York Times Square Hotel in New York City.
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders.
At the end of Friday’s trade, Walter Energy, Inc. (NYSE:WLT)‘s shares surged 18.58% to $0.457.
Walter Energy, Inc. (WLT) declared that on May 15 it will be making interest payments under its indenture agreements with holders of its 9.5% Senior Secured Notes due in 2019 and the 8.5% Senior Notes due in 2021.
The Company formerly had exercised the 30-day payment grace period as it worked with its debtholders to explore alternatives to recapitalize its balance sheet in light of what has been a challenging met coal pricing environment. The Company will continue to engage in such talk about.
Walter Energy, Inc. produces and exports metallurgical coal for the steel industry. It operates through two segments, U.S. Operations, and Canadian and U.K. Operations. The company also extracts, processes, markets, and/or possesses mineral reserves of thermal coal and anthracite coal, in addition to produces metallurgical coke and coal bed methane gas.
Solaredge Technologies Inc (NASDAQ:SEDG), ended its Friday’s trading session with 17.85% gain, and closed at $31.10.
Solaredge Technologies Inc (SEDG) declared its financial results for the fiscal third quarter ended March 31, 2015.
Third Quarter 2015 Highlights
- Record revenue of $86.4 million, up 17.9% from last quarter and 182.7% year-over-year
- GAAP gross margin of 27.4%
- GAAP net income of $6.0 million
- Non-GAAP net income of $8.7 million
- 248 Megawatts AC inverters shipped
Revenues
The Company stated revenues of $86.4 million, an enhance of $13.1 million, or 17.9% from the preceding quarter and an enhance of $55.8 million or 182.7% from the same financial quarter in 2014.
SolarEdge Technologies, Inc. manufactures and supplies DC optimized inverter systems for solar PV installations. The company’s DC optimized inverter system comprises of power optimizers, inverters, and cloud-based monitoring software.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
